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Background
Chronic urticaria (CU) is a debilitating disease that
affects patients’ quality of life (QoL) and the only ques-
tionnaire developed specifically to CU is the Chronic
Urticaria Quality of Life Questionnaire (CU-Q2oL). The
aim of this study was to evaluate the QoL of patients
with CU and to correlate it with disease activity.
Methods
The Brazilian Portuguese version of the CU-Q2oL was
self-administered in 96 adults with CU treated at the
outpatient clinic of a university hospital. Disease activity
was assessed using the Urticaria Activity Score (UAS).
The following characteristics were also studied: age, gen-
der, type of urticarial and duration of disease. ANOVA
was used to compare the results of CU-Q2oL between
the different groups. The relationship between the CU-
Q2oL total score and dimensions and the UAS score
was assessed by Pearson correlation coefficient.
Results
The study population comprised 85% women, with a
median age of 46.5 years (IQR: 31-58.5) and median dis-
ease duration period was 19 months (IQR: 9.25-60). The
main diagnosis was chronic spontaneous urticaria (CSU)
(55.2%), with 21.9% associated with physical urticaria
(PU); 18.8% had chronic autoimmune urticaria (CAIU),
with 11.4% associated with PU, 27.1% had PU alone and
53.1% presented dermographic urticaria. Mean UAS
score was 1.52±1.73 (0-6). The total CU-Q2oL mean
score was 33.39±21 (0-100) and dimension I (sleep/men-
tal state/feeding) had the greatest impact on QoL. The
items with the highest mean score were about itching
(59) and nervousness (58) and the lowest were about
eye edema (34) and sports activities’ limitations (35).
The analysis of variance showed that women had greater
impairment of quality of life in the dimensions I and III
(edema/limitations/appearance) (p=0.02; p=0.01).
Patients with CAIU and PU are more affected in total
score and in all dimensions (p=0.005; p=0.008; p=0.04;
p=0.008). The CU-Q2oL was moderate correlated with
UAS (r=0.45) (p<0.000) and was able to discriminate
between patients with different degrees of disease
severity.
Conclusions
CU patients’ have severely impaired QoL and a signifi-
cant emotional burden. This study showed that women
and patients with CAIU associated with PU had the
greatest QoL impact. CU-Q2oL and UAS are important
instruments not only in research, but also to evaluate
treatment outcomes and must be used in clinical
practice.
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